News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
196 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (38485)
2025 (21720)
Month
January (2961)
February (3165)
March (3318)
April (3244)
May (4160)
June (3267)
July (3145)
August (3370)
September (3134)
October (4161)
November (3326)
December (2436)
Day
2 (146)
3 (183)
4 (142)
5 (133)
6 (66)
9 (118)
10 (126)
11 (144)
12 (125)
13 (104)
16 (199)
17 (196)
18 (185)
19 (186)
20 (104)
23 (157)
24 (189)
25 (193)
26 (210)
27 (157)
30 (181)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
2
3
4
5
6
9
10
11
12
13
16
17
18
19
20
23
24
25
26
27
30
Drug Development
AVEO Pharmaceuticals, Inc. Presents Preclinical Efficacy Data on AV-412, a Novel Oral Tyrosine Kinase Inhibitor of EGFR/HER2 for EGFR Mutant and Drug-Resistant Lung Cancer
April 17, 2007
·
1 min read
Business
Mr. Yoshinobu Ishikawa Appointed President and CEO of Nikon Instruments Inc.
April 17, 2007
·
1 min read
Drug Development
CERVARIX(R), GlaxoSmithKline Cervical Cancer Candidate Vaccine, Demonstrates 100 Percent Protection Against Precancerous Lesions Caused By Cancer-Causing Human Papillomavirus Types 16 & 18 for More Than Five Years
April 17, 2007
·
5 min read
Biotech Beach
Early Stage Pancreatic Cancer Expresses Antigen Targeted by Immunomedics, Inc.'s PAM4 Antibody
April 17, 2007
·
6 min read
Drug Development
Adnexus Therapeutics Announces Presentation at the American Association for Cancer Research on Clinical Product Candidate, CT-322
April 17, 2007
·
1 min read
Business
Gene Logic Inc. Promotes Dr. Thomas Barnes to Lead Drug Repositioning Discovery Efforts
April 17, 2007
·
1 min read
Drug Development
Metabasis Therapeutics, Inc. Presents Results of a Clinical Study for Its Novel Liver-Targeted Product Candidate for the Treatment of HCC at American Association for Cancer Research
April 17, 2007
·
5 min read
Business
Gen-Probe Incorporated Announces Webcast of First Quarter 2007 Earnings Conference Call
April 17, 2007
·
2 min read
Drug Development
Cyclacel Pharmaceuticals, Inc. Reports Preclinical Seliciclib-Erlotinib Synergy Data at American Association for Cancer Research
April 17, 2007
·
1 min read
BioMidwest
Sharon Harkavy, Publisher of Hotshotstocks.com, Today Announced an Exclusive Interview with Mr. Doug Lane CEO and President of Genesis Bioventures
April 17, 2007
·
1 min read
Previous
12 of 20
Next